# Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging

> **NCT03498001** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 42 (actual)

## Conditions studied

- Type II Diabetes

## Interventions

- **DRUG:** GLP-1 agonists
- **PROCEDURE:** Cardiac MRI
- **OTHER:** Follow up by phone

## Key facts

- **NCT ID:** NCT03498001
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-16
- **Primary completion:** 2023-06-06
- **Final completion:** 2023-12-20
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03498001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03498001, "Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03498001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*